President Trump says tariffs have strengthened the economy, but GDP growth was actually below average during the first nine months of 2025. The S&P 500's forward price-to-earnings ratio is above 22, ...
SoundHound AI is developing an agentic AI voice chatbot that already handles restaurant orders. In order to grow outside its current niche, SoundHound needs to develop a cross-industry agentic AI.
U.S. stocks have given up all of their gains for the year, a key index of the so-called Magnificent Seven tech giants has slid into correction territory, and volatility gauges have spiked amid a ...
Nektar Therapeutics (NKTR) added ~24% in the premarket on Tuesday after the company announced that, following positive mid-stage trial data, it is launching a pivotal late-stage program for ...
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple ...
Stocks edged lower as investors considered surprisingly strong labor-market data, while AI jitters continued to pressure software and financial shares. Major U.S. benchmarks were mixed most of the day ...
Financial data-provider stocks dropped after artificial-intelligence company Anthropic announced it added new functions for legal users of its Cowork assistant. While shares of European legal ...
Hosted on MSN
Extracting useful compounds from waste
Human urine contains compounds that can be chemically isolated and studied. One of the primary components is urea, a nitrogen-rich molecule with practical uses. By carefully processing and purifying ...
NEW YORK, Feb 6 (Reuters) - An artificial intelligence-driven shakeout in the heavyweight technology sector is set to keep stock investors on edge in the coming week while a barrage of data could ...
Medical free texts such as pathology reports contain valuable clinical data but are challenging to structure at scale. Traditional natural language processing approaches require extensive annotated ...
The Details: Viking Therapeutics reported quarterly losses of $1.38 per share, which missed the analyst estimate for losses of 89 cents, according to data from Benzinga Pro. Viking said the increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results